Cargando…
Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection
BACKGROUND: Faecal Microbiota Transplant (FMT) has improved outcomes for the treatment of Clostridioides difficile infection (CDI) compared to antibiotic therapy. FMT is classified as a medicinal product in the United Kingdom, similar to the USA and Canada, limiting supply via stool banks without ap...
Autores principales: | McCune, V.L., Quraishi, M.N., Manzoor, S., Moran, C.E., Banavathi, K., Steed, H., Massey, D.C.O, Trafford, G.R, Iqbal, T.H., Hawkey, P.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152830/ https://www.ncbi.nlm.nih.gov/pubmed/32300746 http://dx.doi.org/10.1016/j.eclinm.2020.100301 |
Ejemplares similares
-
Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection
por: Abdali, Zainab I, et al.
Publicado: (2020) -
Faecal microbiota transplantation for Clostridioides
difficile infection: Four years’ experience of the Netherlands
Donor Feces Bank
por: Terveer, Elisabeth M, et al.
Publicado: (2020) -
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice
por: Cammarota, Giovanni, et al.
Publicado: (2019) -
Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank
por: Gill, Madeleine, et al.
Publicado: (2020) -
Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea
por: Jeon, Yong Duk, et al.
Publicado: (2019)